Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | DTOISS◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | DTOISS◆ | 86,979 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | DTOISS◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | UTENDR | 43,861 | $4.00 | $175.4K | -100.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | INZY | Inozyme Pharma, Inc. | AGRANT | 2,815 | $0.74 | $2.1K | +6.9% | Open the original filing on SEC.gov |
| Jun 5, 2025 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |